The flowchart and steps below outlines the best practice for processing industry-written and sponsored clinical trials at UAB. There are many small steps in each of the larger defined steps (see flow ...

With technology/AI taking over administrative and repetitive tasks, human roles will shift towards more strategic, creative, ...

UB's Clinical Research Office helps investigators and their staff to create, establish and manage research that advances our understanding of human health and behavior. The CRO and its staff members ...

In the U.S., there are over 165,000 clinical trials each year. With rising pressure to be first to market and accelerate the speed of research to mitigate growing costs, ensuring the integrity of ...

Perspectives > Second Opinions Diversity Action Plans for Clinical Trials: Evaluating FDA's Draft Guidance — A critical analysis reveals opportunities and challenges prior to finalization ...

More data leads to more precise answers, and the biopharma industry has at its disposal more data than ever before.

Splash Clinical and C2N Diagnostics have collaborated to enhance the recruitment process for clinical trials of Alzheimer's disease across the US and worldwide. This collaboration involves a ...

We have been developing a process for and conducting case studies of successful research since 2017 to learn about the clinical and translational process – how it works when it is working well, as ...

Founded in 2003, the CISCRP is a non-profit organisation that is dedicated to educating the public and patients on the clinical research process, and engaging both as partners.

Applying for funding is a two-step process: You will first need an ID number for your project from SPARCRequest (called a "Project ID"). Visit SPARCRequest and select 'Funding Opportunities' on the ...

The clinical research industry has historically been slow to adopt cutting-edge technology in everyday operations and in many areas continues to use spreadsheets, word processing documents, and ...

Research sponsors and the Food and Drug Administration can respond to this challenge by continuing to support community-based clinical trials.